OGN - Organon & Co.
Close
22.35
0.040 0.179%
Share volume: 1,445,464
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$22.31
0.04
0.18%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-05 | 2022-11-04 | 2023-02-27 | 2023-05-05 | 2023-08-09 | 2023-11-03 | 2024-02-26 | 2024-05-03 | |
| Assets | |||||||||
| Total Assets | 10.614 B | 10.437 B | 10.955 B | 10.763 B | 10.979 B | 11.012 B | 12.058 B | 11.891 B | |
| Current Assets | 3.774 B | 3.592 B | 3.931 B | 3.780 B | 3.958 B | 4.050 B | 4.508 B | 4.196 B | |
| Inventories | 950.000 M | 879.000 M | 1.003 B | 1.121 B | 1.199 B | 1.186 B | 1.315 B | 1.263 B | |
| Other Current Assets | 789.000 M | 774.000 M | 747.000 M | 755.000 M | 761.000 M | 802.000 M | 756.000 M | 811.000 M | |
| Short Term Investments | 789.000 M | 774.000 M | 747.000 M | 755.000 M | 761.000 M | 802.000 M | 756.000 M | 811.000 M | |
| Total Receivables | 1.490 B | 1.440 B | 1.475 B | 1.445 B | 1.672 B | 1.648 B | 1.744 B | 1.547 B | |
| Current Cash | 545.000 M | 499.000 M | 706.000 M | 459.000 M | 326.000 M | 414.000 M | 693.000 M | 575.000 M | |
| Total Non-current Assets | 6.840 B | 6.845 B | 7.024 B | 6.983 B | 7.021 B | 6.962 B | 7.550 B | 7.695 B | |
| Property Plant Equipment | 952.000 M | 906.000 M | 1.018 B | 1.055 B | 1.110 B | 1.096 B | 1.183 B | 1.180 B | |
| Other Assets | 647.000 M | 666.000 M | 754.000 M | 704.000 M | 716.000 M | 702.000 M | 1.231 B | 1.194 B | |
| Intangible Assets | 638.000 M | 670.000 M | 649.000 M | 621.000 M | 592.000 M | 561.000 M | 533.000 M | 718.000 M | |
| Goodwill | 4.603 B | 4.603 B | 4.603 B | 4.603 B | 4.603 B | 4.603 B | 4.603 B | 4.603 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 10.614 B | 10.437 B | 10.955 B | 10.763 B | 10.979 B | 11.012 B | 12.058 B | 11.891 B | |
| Total liabilities | 11.751 B | 11.503 B | 11.847 B | 11.500 B | 11.534 B | 11.601 B | 12.128 B | 11.843 B | |
| Total current liabilities | 2.396 B | 2.328 B | 2.512 B | 2.346 B | 2.387 B | 2.491 B | 2.918 B | 2.545 B | |
| Accounts Payable | 1.130 B | 1.028 B | 1.132 B | 996.000 M | 1.115 B | 1.067 B | 1.314 B | 955.000 M | |
| Other liabilities | 448.000 M | 441.000 M | 411.000 M | 421.000 M | 393.000 M | 421.000 M | 412.000 M | 549.000 M | |
| Current long term debt | 9.000 M | 8.000 M | 8.000 M | 8.000 M | 8.000 M | 8.000 M | 9.000 M | 9.000 M | |
| Long term debt | 8.884 B | 8.691 B | 8.905 B | 8.703 B | 8.722 B | 8.646 B | 8.751 B | 8.705 B | |
| Other liabilities | 448.000 M | 441.000 M | 411.000 M | 421.000 M | 393.000 M | 421.000 M | 412.000 M | 549.000 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -1.137 B | -1.066 B | -892.000 M | -737.000 M | -555.000 M | -589.000 M | -70.000 M | 48.000 M | |
| Common stock | 254.018 M | 254.348 M | 254.379 M | 254.392 M | 255.341 M | 255.588 M | 255.635 M | 255.695 M | |
| Retained earnings | -551.000 M | -383.000 M | -331.000 M | -206.000 M | -25.000 M | -16.000 M | 443.000 M | 573.000 M |